Response to letter to the editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis” Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient
- 4 May 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 27 (4), 1469
- https://doi.org/10.1007/s10741-021-10112-x
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysisHeart Failure Reviews, 2021
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002